chemistry3 papersavg year 2026weak evidence

In vivo pharmacokinetic, biodistribution, efficacy,

Research gap analysis derived from 3 chemistry papers in our local library.

The gap

In vivo pharmacokinetic, biodistribution, efficacy, and safety studies are necessary to establish translational relevance. Further optimization of the nanoparticles is needed to improve their efficacy and reduce their toxicity.

Evidence profile

Sourced from the future-work section and limitations section of the source papers, classified as general, spanning 3 journals.

Research trend

Established — well-defined area with open sub-problems.

Supporting evidence — 3 representative gaps

  • Folic Acid–Conjugated Chitosan Nanoparticles for Colon-Targeted Delivery of Imatinib Mesylate (2026) · BioNanoScience · doi

    In vivo pharmacokinetic, biodistribution, efficacy, and safety studies are necessary to establish translational relevance. Further optimization of the nanoparticles is needed to improve their efficacy and reduce their toxicity.

    generalfuture-work sectionevidence 5/5
    Keywords: vivo pharmacokinetic biodistribution efficacy safety studies necessary establish
  • Green Synthesized Monometallic And Bimetallic Nanoparticles: A Sustainable Approach To Controlled Drug Delivery (2026) · International Journal of Drug Delivery Technology · doi

    Monometallic nanoparticles have limitations such as limited functional diversity, lower stability compared to bimetallic systems, and reduced efficiency in complex therapeutic applications. Scalability, reproducibility, and regulatory approval remain critical barriers to the successful integration of green synthesized nanoparticles into clinical practice.

    generallimitations sectionevidence 5/5
    Keywords: monometallic nanoparticles have limitations limited functional diversity lower
  • Green mycosynthesis of small-sized silver nanoparticles (ss-AgNPs) from endophytic Fusarium solani and their multi-target biomedical profiles (2026) · Scientific Reports · doi

    Optimize synthesis parameters to improve stability and effectiveness of nanoparticles, - Explore mechanistic pathways of biological action, - Conduct in vivo evaluations to validate the safety and therapeutic potential of the ss-AgNPs

    generalfuture-work sectionevidence 5/5
    Keywords: optimize synthesis parameters improve stability effectiveness nanoparticles explore

Questions about this gap

In vivo pharmacokinetic, biodistribution, efficacy, and safety studies are necessary to establish translational relevance. Further optimization of the nanoparticles is needed to im… This is supported by 3 representative gap statements extracted from 3 papers, rated weak evidence.

Explore this gap further

Run this gap as a query across open scholarly engines for the latest related literature.

Working on this gap? Review it with us.

Science AI Journal reviews manuscripts in one pass with 8 specialised AI agents calibrated on 69,000+ real peer reviews.

Related gaps in Chemistry

Command palette

Jump anywhere, run any action.